STOCK TITAN

Opthea to Participate in the 23ʳᵈ Annual Needham Virtual Healthcare Conference 

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Opthea to Present at 23rd Annual Needham Virtual Healthcare Conference
Positive
  • None.
Negative
  • None.

MELBOURNE, Australia and PRINCETON, N.J., April 04, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ: OPT “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD), today announced that management will present at the 23rd Annual Needham Virtual Healthcare Conference and participate in one-on-one investor meetings on April 11, 2024.

23rd Annual Needham Virtual Healthcare Conference Presentation Details:

Date:Thursday, April 11th
Time:3:45 p.m. ET
Presenter:Frederic Guerard, Pharm D, CEO
Webcast LinkHere
  

A webcast of the Needham presentation can be accessed under “Events & Presentations” in the Investor Relations section of the Company’s website, www.opthea.com.

About Opthea

Opthea (ASX/NASDAQ:OPT) is a biopharmaceutical company developing novel therapies to address the unmet need in the treatment of highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME).

Opthea’s lead product candidate, sozinibercept, is being evaluated in two pivotal Phase 3 clinical trials (COAST, NCT04757636, and ShORe, NCT04757610,) for use in combination with standard-of-care anti-VEGF-A monotherapies to improve overall efficacy and deliver superior vision gains compared to the standard-of-care anti-VEGF-A agents. To learn more, visit our website and follow us on X and LinkedIn.

Authorized for release to ASX by Fred Guerard, CEO

Investor Enquiries

PJ Kelleher
LifeSci Advisors, LLC
Email: pkelleher@lifesciadvisors.com
Phone: 617-430-7579

Media:

Silvana Guerci-Lena
NorthStream Global Partners
silvana@nsgpllc.com

Join our email database to receive program updates:
Tel: +61 (0) 3 9826 0399, Email: info@opthea.com, Web: www.opthea.com


FAQ

When will Opthea present at the 23rd Annual Needham Virtual Healthcare Conference?

Opthea will present at the 23rd Annual Needham Virtual Healthcare Conference on April 11, 2024.

Who will be the presenter at the conference?

Frederic Guerard, Pharm D, CEO of Opthea , will be the presenter at the conference.

Where can the webcast of the presentation be accessed?

The webcast of the presentation can be accessed under 'Events & Presentations' on Opthea 's website.

Opthea Limited American Depositary Shares

NASDAQ:OPT

OPT Rankings

OPT Latest News

OPT Stock Data

497.05M
153.87M
3.57%
0.04%
Biotechnology
Healthcare
Link
United States of America
South Yarra